Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: A possible alternative ovarian clear-cell carcinogenic pathway

Journal of Pathology

Volumn 216, Issue 1, 2008, Pages 103-110

  Yamamoto, S ^a   Tsuda, H ^a,b   Takano, M ^a   Hase, K ^c   Tamai, S ^a   Matsubara, O ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c Self Defense Forces Central Hospital   (Japan)

Author keywords

Adenofibroma; Carcinogenesis; Microdissection; Ovarian cancer; Ovary; Precursor

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CHI SQUARE TEST; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 5Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME 9Q; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DNA ISOLATION; FEMALE; FIBROMA; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; OVARY ADENOCARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROBABILITY; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA, CLEAR CELL; ADENOFIBROMA; ALLELES; CHI-SQUARE DISTRIBUTION; CHROMOSOME MAPPING; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 50249102281     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2386     Document Type: Article

References (20)

1. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In Blaustein's Pathology of the Female Genital Tract, 5th edn, Kurman RJ (ed.). Springer-Verlag: New York, 2001; 791-904.
2. Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y. Kita T, et at. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000,88:2584-2589.
3. Ikeda K, Sakai K, Yamamoto R, Hareyama H, Tsumura N, Watari H, et al. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II - IV ovarian cancer. Int J Gynecol Cancer 2003;13:776-784.
4. Tavassoli FA, Devilee P (eds). World Health Organization classification of tumours. In Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press: Lyon, 2003; 218-228.
5. Kaku T, Ogawa S, Kawano Y, Ohishi Y, Kobayashi H, Hirakawa T, et al. Histological classification of ovarian cancer. Med Electron Microsc 2003;36:9-17.
6. Gynecologic Cancer Committee, Japan Society of Obstetrics and Gynecology. Annual report of gynecological cancer patients in Japan 2006. Acta Obstet Gynecol Japon 2008;60:1001-1085 [in Japanese].
7. Vercellini P, Parazzini F, Bolis G, Carinelli S, Dindelli M, Vendola N, et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol 1993;169:181-182.
8. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997;30:249-255.
9. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ, et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996;56:3534-3539.
10. Jiang X, Morland SJ, Hitchcock A, Thomas EJ, Campbell IG. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res 1998;58:1707-1712.
11. Obata K, Hoshiai H. Common genetic changes between endometriosis and ovarian cancer. Gynecol Obstet Invest 2000;50:39-43.
12. Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000;60:7052-7056.
13. Bell DA, Scully RE. Benign and borderline clear cell adenofibromas of the ovary. Cancer 1985;56:2922-2931.
14. Roth LM, Langley FA, Fox H, Wheeler JE, Czernobilsky B. Ovarian clear cell adenofibromatous tumors: benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 1984;53:1156-1163.
15. Yamamoto S, Tsuda H, Yoshikawa T, Kudoh K, Kita T, Furuya K, et al. Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathological characteristics. Am J Surg Pathol 2007;31:999-1006.
16. Okada S, Tsuda H, Takarabe T, Yoshikawa H, Taketani Y, Hirohashi S. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types. Japan J Cancer Res 2002;93:798-806.
17. Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, et al. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst 1992;84:1793-1798.
18. Abeln EC, Kuipers-Dijkshoom NJ, Berns EM, Henzen-Logmans SC, Fleuren GJ, Cornelisse CJ. Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence. Br J Cancer 1995;72:1330-1336.
19. Lasko D, Cavenee W, Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 1991;25:281-314.
20. Thiagalingam S, Laken S, Willson JK, Markowitz SD, Kin-zler KW, Vogelstein B, et al. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci USA 2001;98:2698- 2702.